News & Updates

The use of clopidogrel for long-term antiplatelet monotherapy during the maintenance phase after percutaneous coronary intervention (PCI) results in reduced adverse cardiovascular and bleeding outcomes compared with aspirin, as shown in the secondary analysis of the HOST-EXAM study.

In the treatment of frail older patients with non–ST-elevation myocardial infarction (NSTEMI), an invasive strategy does not appear to provide additional benefit compared with a conservative strategy and may even contribute to an increased risk of harm in those at the highest levels of frailty, according to the secondary analysis of the SENIOR-RITA trial.

Cognitive function deterioration commonly occurs years prior to cardiovascular disease (CVD) events in older adults, as shown in a nested case-control study.

Exposure to residential greenness in COVID-19 survivors appears to reduce the risk of chronic ischaemic heart disease but not that of acute coronary events, as reported in a cohort study from South Korea.

New research indicates that among patients with hypertension, COVID-19 contributes to an increased risk of poorer cardiovascular (CV) outcomes.

Among women undergoing in vitro fertilization (IVF) treatment, those who have stage 1 or 2 hypertension prior to the initiation of ovarian stimulation may have reduced chances of a live birth and increased risks of pregnancy complications, according to a large retrospective study.

The use of an artificial intelligence (AI)-based tool results in a 31-percent enhanced precision in sudden cardiac death (SCD) phenotyping in electronic heart records (EHR), a recent study has shown.